Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

Severe Hypothyroidism Induced by Thyroid Metastasis of Cholangiocarcinoma

Bae WK, Shim HJ, Choi YD, Kim JW, Cho SH, Kang HC, Chung IJ

  • Cancer Res Treat.
  • 2009 Mar;41(1):56-58.
We report a case of severe hypothyroidism in a cholangiocarcinoma patient with metastasis to the thyroid gland. A 58-year-old man was admitted for upper abdominal discomfort and multiple palpable neck...
A Case of Gemcitabine and Cisplatin Associated Posterior Reversible Encephalopathy Syndrome

Kwon EJ, Kim SW, Kim KK, Seo HS, Kim DY

  • Cancer Res Treat.
  • 2009 Mar;41(1):53-55.
A 58-year-old female receiving gemcitabine and cisplatin chemotherapy for stage IV gallbladder cancer developed the clinicoradiologic syndrome, posterior reversible encephalopathy syndrome (PRES). Just before the 4th gemcitabine chemotherapy cycle, she...
Herpes Zoster Duplex Bilateralis in a Patient with Breast Cancer

Yoo KH, Park JH, Kim BJ, Kim MN, Song KY

  • Cancer Res Treat.
  • 2009 Mar;41(1):50-52.
The skin lesion of herpes zoster is classically limited to a single dermatome, and most cases of multi-dermatomal herpes zoster have contiguous skin lesions. Noncontigous multi-dermatomal herpes zoster is very...
Cancer of Unknown Primary Finally Revealed to Be a Metastatic Prostate Cancer: A Case Report

Cho JY, Shim EJ, Kim IS, Nam EM, Choi MY, Lee KE, Mun YC, Seoung CM, Lee SN, Song DE, Han WS

  • Cancer Res Treat.
  • 2009 Mar;41(1):45-49.
The vast majority of patients with metastatic prostate cancer present with bone metastases and high prostate specific antigen (PSA) level. Rarely, prostate cancer can develop in patients with normal PSA...
Proapoptotic Ginsenosides Compound K and Rh2 Enhance Fas-induced Cell Death of Human Astrocytoma Cells Through Distinct Apoptotic Signaling Pathways

Choi K, Choi C

  • Cancer Res Treat.
  • 2009 Mar;41(1):36-44.
PURPOSE: Malignant astrocytomas are among the commonest primary brain tumors and they have a grave prognosis, and so there is an urgent need to develop effective treatment. In this study,...
Osteopontin, CD44, and NFkappaB Expression in Gastric Adenocarcinoma

Kim JY, Bae BN, Kim KS, Shin E, Park K

  • Cancer Res Treat.
  • 2009 Mar;41(1):29-35.
PURPOSE: Osteopontin (OPN) binds to CD44 and nuclear factor-kappaB (NFkappaB) and OPN mediates tumorigenesis, invasion and metastasis, but the interrelationships between OPN, CD44 and NFkappaB are not fully understood, and...
Uterine Leiomyosarcoma : 14-year Two-center Experience of 31 Cases

Kim WY, Chang SJ, Chang KH, Yoon JH, Kim JH, Kim BG, Bae DS, Ryu HS

  • Cancer Res Treat.
  • 2009 Mar;41(1):24-28.
PURPOSE: The aim of this study was to evaluate the clinicopathological characteristics of uterine leiomyosarcoma (LMS) and possible prognostic factors. MATERIALS AND METHODS: This study included 31 patients with histologically proven...
The Effect of Adjuvant Chemotherapy on Stage IV (T4N1-3M0 and T1-3N3M0) Gastric Cancer

Ha TK, Jung MS, Lee KH, Lee KG, Kwon SJ

  • Cancer Res Treat.
  • 2009 Mar;41(1):19-23.
PURPOSE: The optimal chemotherapeutic strategy for gastric cancer patients has not been determined, especially with respect to stage and the curability of gastric cancer. The aim of this study was...
Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer

Lee KH, Hyun MS, Kim HK, Jin HM, Yang J, Song HS, Do YR, Ryoo HM, Chung JS, Zang DY, Lim HY, Jin JY, Yim CY, Park HS, Kim JS, Sohn CH, Lee SN

  • Cancer Res Treat.
  • 2009 Mar;41(1):12-18.
PURPOSE: Heptaplatin (Sunpla) is a cisplatin derivative. A phase IIb trial using heptaplatin resulted in a 34% response rate with mild nephrotoxicity. We conducted a randomized phase III trial of...
Advances of Cancer Therapy by Nanotechnology

Wang X, Wang Y, Chen ZG, Shin DM

  • Cancer Res Treat.
  • 2009 Mar;41(1):1-11.
Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr